Skip to Content

Pharmaceutical Sales 2010

The following is a list of the top 200 pharmaceutical drugs by retail sales in 2010, listed by U.S. sales value and brand name.
Quarterly top 100 prescription sales data now available, from Q1 2011.

Top 200 Drugs for 2010 by Sales

(By Units)

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012

Rank Drug Current Manufacturer Total Sales ($000) % Change 2009
1 (1) Nexium AstraZeneca 5,276,153 4.9%
2 (1) Lipitor Pfizer Inc. 5,272,576 -2.3%
3 Plavix Bristol-Myers Squibb Company 4,675,483 10.2%
4 Advair Diskus GlaxoSmithKline 3,655,206 -1.0%
5 (3) OxyContin Purdue Pharma LP 3,554,751 13.1%
6 Abilify Bristol-Myers Squibb Company 3,514,265 12.7%
7 Singulair Merck 3,324,909 8.9%
8 (3) Seroquel AstraZeneca 3,222,055 2.4%
9 (5) Crestor AstraZeneca 2,922,687 27.0%
10 (1) Cymbalta Eli Lilly and Company 2,638,536 7.6%
11 (2) Actos Takeda Pharmaceuticals U.S.A., Inc. 2,631,930 4.2%
12 (1) Lexapro Actavis Pharma, Inc. 2,483,391 4.6%
13 (2) Zyprexa Eli Lilly and Company 2,036,092 7.7%
14 (9) Spiriva Boehringer Ingelheim Pharmaceuticals, Inc. 1,593,593 19.3%
15 (3) Lantus Sanofi 1,525,697 0.3%
16 (6) Aricept Eisai Inc. 1,522,517 13.3%
17 (2) Lyrica Pfizer Inc. 1,478,158 -0.1%
18 (6) Diovan Novartis Pharmaceuticals Corporation 1,443,539 7.0%
19 (7) Effexor XR Pfizer Inc. 1,431,042 -40.1%
20 (7) Concerta Janssen Pharmaceuticals, Inc. 1,407,962 16.9%
21 Levaquin Janssen Pharmaceuticals, Inc. 1,355,350 -0.6%
22 (2) Celebrex Pfizer Inc. 1,349,833 -6.9%
23 (2) Diovan HCT Novartis Pharmaceuticals Corporation 1,314,507 3.7%
24 (4) Januvia Merck 1,294,408 13.0%
25 (16) Suboxone Reckitt Benckiser Pharmaceuticals Inc. 1,164,872 26.6%
26 (14) NovoLog Novo Nordisk 1,101,447 20.6%
27 (9) Viagra Pfizer Inc. 1,028,769 5.5%
28 (4) Atripla Bristol-Myers Squibb Company 1,028,753 -6.5%
29 (3) Tricor Abbott Laboratories 1,015,682 -17.2%
30 (13) Provigil Cephalon, Inc. 999,975 6.7%
31 (2) Zetia Merck 985,823 -4.3%
32 (12) Geodon oral Pfizer Inc. 959,057 8.7%
33 (4) Vytorin Merck 953,625 -16.3%
34 (1) Ambien CR Sanofi 951,108 -2.5%
35 (11) Lunesta Sepracor Inc. 948,621 17.6%
36 (2) Lidoderm Endo Pharmaceuticals Inc. 934,418 -1.1%
37 (22) Lantus SoloSTAR Sanofi 933,589 50.5%
38 (15) Vyvanse Takeda Pharmaceuticals U.S.A., Inc. 931,421 40.9%
39 (5) Aciphex Eisai Inc. 915,796 -8.8%
40 (2) Nasonex Merck 886,446 -1.9%
41 (10) Lovenox Sanofi 867,240 -20.4%
42 (12) Adderall XR Takeda Pharmaceuticals U.S.A., Inc. 837,448 -27.0%
43 (4) ProAir HFA Teva Pharmaceuticals USA, Inc. 818,903 -12.6%
44 (1) Truvada Gilead Sciences, Inc. 813,944 -8.5%
45 (3) Niaspan Abbott Laboratories 793,882 11.0%
46 (1) Humalog Eli Lilly and Company 783,294 3.2%
47 (8) Cialis Eli Lilly and Company 756,576 15.9%
48 (4) Namenda Actavis Pharma, Inc. 744,296 10.9%
49 (27) Symbicort AstraZeneca 707,468 47.4%
50 (8) Flovent HFA GlaxoSmithKline 704,631 13.2%
51 (52) Seroquel XR AstraZeneca 695,560 92.1%
52 (8) Combivent Boehringer Ingelheim Pharmaceuticals, Inc. 693,068 14.3%
53 () Lovaza GlaxoSmithKline 682,384 15.5%
54 (24) Solodyn Medicis Pharmaceutical Corporation 673,427 40.7%
55 (6) Detrol LA Pfizer Inc. 620,231 -13.6%
56 (8) AndroGel Abbott Laboratories 593,780 10.1%
57 (10) Benicar Daiichi Sankyo 567,636 10.0%
58 (38) Levemir Novo Nordisk 567,341 41.1%
59 (2) Enbrel Amgen Inc. 546,814 -15.8%
60 (44) Valtrex GlaxoSmithKline 533,961 -69.9%
61 (2) Benicar HCT Daiichi Sankyo 526,177 -3.1%
62 (7) Gleevec Novartis Pharmaceuticals Corporation 517,967 -3.7%
63 (14) Humira Pen Abbott Laboratories 514,735 10.1%
64 (10) Synthroid Abbott Laboratories 506,859 2.5%
65 (20) Xalatan Pfizer Inc. 502,227 9.1%
66 (2) Premarin tabs Pfizer Inc. 497,757 -6.5%
67 (5) Strattera Eli Lilly and Company 496,960 -3.9%
68 (46) Ventolin HFA GlaxoSmithKline 496,659 65.4%
69 (52) Flomax Boehringer Ingelheim Pharmaceuticals, Inc. 486,106 -68.9%
70 (52) Loestrin 24 Fe Allergan plc 483,754 82.3%
71 (13) Protonix Pfizer Inc. 481,429 3.5%
72 (1) Boniva Genentech, Inc. 480,470 -5.3%
73 (22) Restasis Actavis Pharma, Inc. 480,414 19.0%
74 (14) Femara Novartis Pharmaceuticals Corporation 477,256 12.7%
75 (18) Enbrel Sureclick Amgen Inc. 474,602 2.6%
76 (17) NovoLog Mix 70/30 Novo Nordisk 470,786 16.8%
77 (6) Evista Eli Lilly and Company 469,013 0.3%
78 (16) Byetta Amylin Pharmaceuticals, Inc. 459,454 -17.8%
79 (20) Janumet Merck 459,068 22.7%
80 (5) Asacol Actavis Pharma, Inc. 450,645 -8.3%
81 (9) Avodart GlaxoSmithKline 441,486 5.5%
82 (16) Vesicare Astellas Pharma US, Inc. 440,862 15.3%
83 (68) Trilipix Abbott Laboratories 428,978 104.5%
84 (3) Copaxone Accredo Health Group, Inc. 421,758 1.3%
85 (19) Focalin XR Novartis Pharmaceuticals Corporation 416,245 18.6%
86 (16) Reyataz Bristol-Myers Squibb Company 412,293 -20.9%
87 (37) Pristiq Pfizer Inc. 411,715 58.4%
88 (32) Arimidex AstraZeneca 403,891 -37.5%
89 (9) Chantix Pfizer Inc. 394,944 -14.3%
90 (10) Sensipar Amgen Inc. 382,232 -0.5%
91 (3) Avapro Bristol-Myers Squibb Company 369,596 -6.2%
92 (49) Opana ER Endo Pharmaceuticals Inc. 366,417 52.5%
93 (43) Yaz Bayer HealthCare Pharmaceuticals Inc. 361,958 -49.1%
94 (27) Doryx Actavis Pharma, Inc. 361,662 35.7%
95 (13) Actoplus Met Takeda Pharmaceuticals U.S.A., Inc. 359,790 4.7%
96 (19) Humira Abbott Laboratories 358,012 -12.5%
97 Avelox Bayer HealthCare Pharmaceuticals Inc. 353,130 -8.4%
98 (13) NuvaRing Merck 349,014 11.0%
99 () Renvela Genzyme Corporation 333,987 111.5%
100 (35) Ortho Tri-Cyclen Lo Janssen Pharmaceuticals, Inc. 331,730 33.9%
101 (28) Lamictal GlaxoSmithKline 326,331 -35.2%
102 (4) Avalide Bristol-Myers Squibb Company 324,571 -6.4%
103 (1) Xopenex Akorn, Inc. 316,162 -13.0%
104 (18) Actonel Actavis Pharma, Inc. 313,904 -29.0%
105 () Dexilant/Kapidex 313,386 254.8%
106 (4) Lotrel Novartis Pharmaceuticals Corporation 306,010 -6.8%
107 (9) Invega Janssen Pharmaceuticals, Inc. 304,182 5.1%
108 (24) Welchol Daiichi Sankyo 303,392 19.7%
109 (11) Avonex Biogen 303,147 0.2%
110 (73) Topamax Janssen Pharmaceuticals, Inc. 287,186 -70.5%
111 (1) Norvir Abbott Laboratories 287,102 -10.0%
112 (46) Entocort EC AstraZeneca 282,547 38.6%
113 (15) Aggrenox Boehringer Ingelheim Pharmaceuticals, Inc. 277,144 6.5%
114 (51) Travatan Z Alcon 273,598 44.1%
115 Isentress Merck 272,132 -9.8%
116 (25) Avandia GlaxoSmithKline 269,213 -33.8%
117 Prevacid SoluTab Takeda Pharmaceuticals U.S.A., Inc. 268,284 -1.4%
118 (27) Exforge Novartis Pharmaceuticals Corporation 267,771 16.6%
119 (68) Cozaar Merck 267,081 -62.4%
120 (9) Lumigan Actavis Pharma, Inc. 267,047 7.0%
121 (12) Caduet Pfizer Inc. 266,967 -18.6%
122 (36) Actonel 150 Actavis Pharma, Inc. 264,858 26.2%
123 (5) Risperdal Consta Janssen Pharmaceuticals, Inc. 262,054 -8.2%
124 (59) Prograf Astellas Pharma US, Inc. 260,885 -56.2%
125 (27) Ciprodex otic Alcon 254,888 13.8%
126 (23) Vigamox Alcon 252,864 11.3%
127 (7) Kadian Actavis Pharma, Inc. 251,858 -0.8%
128 (2) Coreg CR GlaxoSmithKline 251,440 -1.6%
129 (4) Levitra Bayer HealthCare Pharmaceuticals Inc. 242,446 -5.9%
130 (8) Maxalt Merck 242,237 0.5%
131 (24) Keppra UCB, Inc. 241,737 -33.0%
132 (122) Prevacid Takeda Pharmaceuticals U.S.A., Inc. 241,374 -90.6%
133 (27) Micardis Boehringer Ingelheim Pharmaceuticals, Inc. 238,335 23.9%
134 () Bystolic Actavis Pharma, Inc. 231,449 72.2%
135 (28) Prezista Janssen Biotech, Inc. 230,406 13.8%
136 (52) Exelon Patch Novartis Pharmaceuticals Corporation 229,601 38.2%
137 () Nuvigil Cephalon, Inc. 223,885 239.6%
138 (2) Zyvox Pfizer Inc. 222,554 -7.5%
139 (41) Lialda Takeda Pharmaceuticals U.S.A., Inc. 222,201 29.3%
140 (15) Epzicom GlaxoSmithKline 221,406 -17.0%
141 (20) Enablex Actavis Pharma, Inc. 220,478 11.0%
142 (19) Forteo Eli Lilly and Company 219,387 -25.1%
143 (7) Viread Gilead Sciences, Inc. 216,264 -6.2%
144 (31) Kaletra Abbott Laboratories 212,723 -32.9%
145 (17) Micardis HCT Abbott Laboratories 211,575 10.4%
146 (8) Maxalt MLT Merck 211,230 -1.1%
147 Humalog Mix 75/25 Pen Eli Lilly and Company 211,021 -6.9%
148 (12) Xeloda Genentech, Inc. 209,499 -11.7%
149 (7) Asmanex Merck 208,839 3.8%
150 (84) Hyzaar Merck 207,471 -62.3%
151 (20) Fentora Cephalon, Inc. 207,376 11.2%
152 (91) Pulmicort Respules AstraZeneca 205,218 -68.0%
153 () Ranexa Gilead Sciences, Inc. 200,622 41.5%
154 (49) RenaGel Genzyme Corporation 199,275 -48.2%
155 (34) Prempro Pfizer Inc. 198,132 22.2%
156 (1) Relpax Pfizer Inc. 197,341 -3.4%
157 (12) Patanol Alcon 196,500 2.6%
158 (8) Amitiza Takeda Pharmaceuticals U.S.A., Inc. 195,132 1.4%
159 (4) Duragesic Janssen Pharmaceuticals, Inc. 194,599 -14.5%
160 () Vancocin HCl Eli Lilly and Company 192,066 23.4%
161 (22) Nasacort AQ Sanofi 192,035 -19.0%
162 (35) Proventil HFA Merck 191,839 -26.5%
163 () Advair HFA GlaxoSmithKline 191,245 26.4%
164 (14) Valcyte Genentech, Inc. 191,160 -0.9%
165 (21) Wellbutrin XL Bausch Health Companies Inc. 189,026 -21.2%
166 () Oracea Galderma Laboratories, L.P. 187,182 67.9%
167 (18) Vivelle-DOT Novartis Pharmaceuticals Corporation 185,860 12.4%
168 (11) Uroxatral Concordia Pharmaceuticals Inc. 185,624 6.2%
169 (8) Zovirax topical GlaxoSmithKline 184,377 2.6%
170 (27) Epipen King Pharmaceuticals, Inc. 182,785 20.8%
171 () Creon Abbott Laboratories 181,303 358.6%
172 () Azor Daiichi Sankyo 179,647 33.0%
173 (9) Pentasa Sanofi 178,068 4.5%
174 (32) Procrit Janssen Biotech, Inc. 174,622 -25.9%
175 () Pataday Alcon 173,553 25.5%
176 (30) Differin Galderma Laboratories, L.P. 171,454 -24.8%
177 (10) Premarin vaginal Pfizer Inc. 170,860 3.5%
178 () Zyprexa Zydis Eli Lilly and Company 169,714 6.7%
179 (36) Tussionex Sanofi 169,611 -29.8%
180 () Victoza Novo Nordisk 168,943 0.0%
181 () Humalog KwikPen Eli Lilly and Company 168,270 79.6%
182 () Arixtra GlaxoSmithKline 165,530 19.9%
184 (36) Combivir GlaxoSmithKline 163,406 -27.8%
185 () Testim Endo Pharmaceuticals Inc. 163,015 12.2%
186 (60) Tarceva Astellas Pharma US, Inc. 160,591 -38.2%
187 (17) Xyzal Sanofi 160,237 -15.6%
188 (12) Elmiron Bayer HealthCare Pharmaceuticals Inc. 158,274 4.3%
189 (5) Propecia Merck 157,892 -5.7%
190 (108) CellCept Genentech, Inc. 157,743 -68.3%
191 (110) Skelaxin Elan Corporation plc 156,372 -67.7%
192 () Betaseron Bayer HealthCare Pharmaceuticals Inc. 155,952 -6.8%
193 (12) Temodar Merck 154,466 -14.9%
194 () Flector Actavis Pharma, Inc. 153,814 0.2%
195 (27) Pegasys Genentech, Inc. 153,101 -8.4%
196 (6) Prandin Novo Nordisk 151,678 -5.9%
197 (5) Veramyst GlaxoSmithKline 150,582 -7.8%
198 () Intuniv Takeda Pharmaceuticals U.S.A., Inc. 150,346 NA
199 () Clobex Galderma Laboratories, L.P. 150,230 20.6%
200 () Humulin N Eli Lilly and Company 149,945 4.4%

Source: Verispan, VONA

(By Units)

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012